Citurgia Biochemicals Limited

As of June 30, 2026, Citurgia Biochemicals Limited carries a market capitalization of 15.53B, placing it among publicly traded companies globally. Its enterprise value stands at 15.53B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Citurgia Biochemicals Limited has 132.10M shares outstanding.

These figures cover the twelve months ended June 30, 2026. The company generates approximately - - in revenue per employee across its workforce of 2.00, a quick read on workforce productivity versus industry peers.

As of the close on October 19, 2026, Citurgia Biochemicals Limited's stock has declined approximately 35.24% over the past 52 weeks. The 50-day moving average sits at 104.52, while the 200-day moving average is 140.86.

Over the twelve months ended June 30, 2026, Citurgia Biochemicals Limited generated - - in revenue and converted that into -7.41M in net income, yielding earnings per share of -0.06. EBITDA reached -5.15M, while operating income came in at -7.41M.

Citurgia Biochemicals Limited's most recent stock split took place on April 23, 2007 with a 20:1 split ratio.